Aspira Women's Health (AWH) Stock Price, News & Analysis

Company Overview

Aspira Women's Health, Inc. engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.

Key Stats

• Today's Range: $0.08 to $0.09
• 50-Day Range: $0.08 to $0.08
• 52-Week Range: $0.08 to $1.56
• Volume: 4.31 million shs
• Average Volume: 1.62 million shs
• Market Capitalization: $2.44 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $5.50
• Consensus Rating: Buy

AWH Stock Analysis - Frequently Asked Questions

How were Aspira Women's Health's earnings last quarter?

Aspira Women's Health Inc. (NASDAQ:AWH) issued its quarterly earnings results on Thursday, March, 27th. The company reported ($0.08) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.21) by $0.13. The firm had revenue of $2.35 million for the quarter, compared to analyst estimates of $3 million.

When did Aspira Women's Health's stock split?

Aspira Women's Health's stock reverse split on Friday, May 12th 2023.The 1-15 reverse split was announced on Friday, May 12th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 12th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

What other stocks do shareholders of Aspira Women's Health own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Aspira Women's Health investors own include Tesla (TSLA), Moderna (MRNA), Plug Power (PLUG), Riot Platforms (RIOT), Himax Technologies (HIMX) and HIVE Digital Technologies (HIVE).

Company Calendar

• Last Earnings: 3/27/2025
• Today: 7/26/2025
• Next Earnings (Estimated): 8/11/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Diagnostic substances
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:AWH
• CIK: 926617
• Web: www.aspirawh.com
• Phone: 512-519-0400
• Fax: 512-439-6908
• Employees: 110
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Aspira Women's Health: $5.50
• High Price Target: $5.50
• Low Price Target: $5.50
• Potential Upside/Downside: +6,607.3%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.98)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$16.69 million
• Net Margins: -165.07%
• Pretax Margin: -165.07%
• Return on Equity: N/A
• Return on Assets: -267.23%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.75
• Quick Ratio: 0.70

Sales & Book Value

• Annual Sales: $9.18 million
• Price / Sales: 0.27
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.23) per share
• Price / Book: -0.36

Miscellaneous

• Outstanding Shares: 29,764,000
• Free Float: 16,915,000
• Market Cap: $2.44 million
• Optionable: No Data
• Beta: 2.01